The material selection platform
Plastics & Elastomers
The material selection platform
Plastics & Elastomers
by SpecialChem
Cette page a bien été ajoutée à vos favoris

Mediprene® 500650M

Technical Datasheet | Supplied by HEXPOL COMPOUNDING
Mediprene® 500650M by Hexpol is a biocompatible thermoplastic elastomer (TPE) containing SEBS rubber, paraffinic oil and polypropylene. It is free from polyvinyl chloride (PVC), silicon and latex. Exhibits flexibility, elasticity, colorability, soft-touch, short cycle times, resistance to weather, chemicals and fluids used in healthcare environment. It adheres to polypropylene (PP) or polyethylene (PE) without modifying overmolding and coextrusion processes and it is suitable for processing by extrusion and injection molding. Recommended applications include face masks, incontinence care products, connectors, IV systems, intubation equipment, seals, resealable membranes, drip chambers, wound care products, tubing, medical packaging and soft touch grips on medical devices. Mediprene® 500650M complies with biocompatibility according to USP Class VI, FDA 21CFR, 2002/72/EC, ISO 9001, ISO 14001 and ISO 13485 regulations.
Product Type
Unspecified TPE
Product Status

Mediprene® 500650M Properties

Mechanical Properties

Value & Unit
Test Condition
Test Method
Tensile Strength
10 MPa
( )
Tear Strength
37 kN/m
( )
Hardness, Shore A
(At 4 mm)
ASTM D2240

Mediprene® 500650M Processing Guidelines

Extrusion/Injection Molding Properties

Value & Unit
Test Condition
Test Method
Mold Temperature
180 - 210 °C
Help us improve the Universal Selector

You can’t find what you are looking for? Please report missing products / suppliers, point out errors, or simply tell us how we could make the Universal Selector better.

Access Reliable
Product Information

Database of 145794 Plastics & Elastomers,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top